High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer

Authors: 
van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, Guzmán-Ramírez N, Hamdy FC, Eaton CL, Thalmann GN, Cecchini MG, Pelger RC, van der Pluijm G.
Institution: 
Department of Urology, Leiden University Medical Center, Leiden
Country: 
The Netherlands
Year: 
2010
Journal Name: 
Cancer Research

Metastatic progression of advanced prostate cancer is a major clinical problem. Identifying the cell(s) of origin in prostate cancer and its distant metastases may permit the development of more effective treatment and preventive therapies. In this study, aldehyde dehydrogenase (ALDH) activity was used as a basis to isolate and compare subpopulations of primary human prostate cancer cells and cell lines. ALDH-high prostate cancer cells displayed strongly elevated clonogenicity and migratory behavior in vitro. More strikingly, ALDH-high cells readily formed distant metastases with strongly enhanced tumor progression at both orthotopic and metastatic sites in preclinical models. Several ALDH isoforms were expressed in human prostate cancer cells and clinical specimens of primary prostate tumors with matched bone metastases. Our findings suggest that ALDH-based viable cell sorting can be used to identify and characterize tumor-initiating and, more importantly perhaps, metastasis-initiating cells in human prostate cancer.

Tissue Type: 
Prostate
Tissue Info: 

Primary prostate cancer samples obtained after radical prostatectomy

Species: 
Human
CELLnTEC Products: 
Product Use: 

Isolation and cultivation for qPCR controlled tumorigenicity confirmation, ALDEFLUOR assay and fluorescence-activated cell sorting, mRNA expression, soft agar colony assay, colony-forming assay, migration assay

Website designed and created by:
Holler iNetCom